Literature DB >> 12385543

Evidence for activation of cellular immune responses in patients with acute hepatitis E.

Sita Naik1, Rakesh Aggarwal, Subhash R Naik, Sunita Dwivedi, Sudha Talwar, S K Tyagi, S D Duhan, P Coursaget.   

Abstract

INTRODUCTION: Although acute hepatitis E virus (HEV) infection is known to induce IgM and IgG humoral host immune responses, little is known about occurrence of cellular responses in this infection. We looked for evidence of lymphocyte sensitization to HEV peptides in patients with acute HEV infection.
METHODS: peripheral blood lymphocytes were obtained from patients with acute hepatitis E and healthy controls. Proliferation of these lymphocytes in the presence of each of seven peptides with amino acid sequences corresponding to open reading frames 2 and 3 proteins of HEV (3 and 4 peptides, respectively) were studied; no peptide was added to control wells. Proliferative responses with stimulation indices exceeding 3.0 were taken as positive.
RESULTS: More patients showed reactivity to two or more HEV peptides than did controls (11/21 vs 5/22, p<0.05). Reactivity to one peptide corresponding to open reading frame 2 of HEV was more frequent in patients than in controls (7/21 vs 1/22, p<0.05).
CONCLUSION: Our results show that lymphocytes of patients with acute hepatitis E show sensitization to HEV peptides. This may have significance in understanding the pathogenetic mechanisms of liver injury in this infection.

Entities:  

Mesh:

Year:  2002        PMID: 12385543

Source DB:  PubMed          Journal:  Indian J Gastroenterol        ISSN: 0254-8860


  9 in total

1.  Risk factors and immune response to hepatitis E viral infection among acute hepatitis patients in Assiut, Egypt.

Authors:  Salwa S Seif Eldin; Ismail Seddik; Enas A Daef; M T Shata; Marwa Raafat; Laila Abdel Baky; M A Nafeh
Journal:  Egypt J Immunol       Date:  2010

Review 2.  Natural History, Clinical Manifestations, and Pathogenesis of Hepatitis E Virus Genotype 1 and 2 Infections.

Authors:  Rakesh Aggarwal; Amit Goel
Journal:  Cold Spring Harb Perspect Med       Date:  2019-07-01       Impact factor: 6.915

3.  T-cell epitope mapping of ORF2 and ORF3 proteins of human hepatitis E virus.

Authors:  R Aggarwal; R Shukla; S Jameel; S Agrawal; P Puri; V K Gupta; A P Patil; S Naik
Journal:  J Viral Hepat       Date:  2007-04       Impact factor: 3.728

4.  Characterization of hepatitis E-specific cell-mediated immune response using IFN-gamma ELISPOT assay.

Authors:  M T Shata; A Barrett; N J Shire; S F Abdelwahab; M Sobhy; E Daef; S S El-Kamary; M Hashem; R E Engle; R H Purcell; S U Emerson; G T Strickland; K E Sherman
Journal:  J Immunol Methods       Date:  2007-09-19       Impact factor: 2.303

5.  Cellular immune responses in acute hepatitis E virus infection to the viral open reading frame 2 protein.

Authors:  Ruchi Srivastava; Rakesh Aggarwal; Shahid Jameel; Pankaj Puri; Vijay K Gupta; V S Ramesh; Shobna Bhatia; Sita Naik
Journal:  Viral Immunol       Date:  2007       Impact factor: 2.257

6.  Hepatitis E: a complex and global disease.

Authors:  E Pelosi; I Clarke
Journal:  Emerg Health Threats J       Date:  2008-11-07

7.  Codon-Optimized Expression and Purification of Truncated ORF2 Protein of Hepatitis E Virus in Escherichia coli.

Authors:  Fatemeh Farshadpour; Reza Taherkhani; Manoochehr Makvandi; Hamid Rajabi Memari; Ali Reza Samarbafzadeh
Journal:  Jundishapur J Microbiol       Date:  2014-07-01       Impact factor: 0.747

Review 8.  Viral hepatitis in pregnancy.

Authors:  Mohamed Tarek M Shata; Helal F Hetta; Yeshika Sharma; Kenneth E Sherman
Journal:  J Viral Hepat       Date:  2022-07-07       Impact factor: 3.517

9.  Development of enzyme-linked immunosorbent assays using 2 truncated ORF2 proteins for detection of IgG antibodies against hepatitis E virus.

Authors:  Reza Taherkhani; Manoochehr Makvandi; Fatemeh Farshadpour
Journal:  Ann Lab Med       Date:  2014-02-13       Impact factor: 3.464

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.